Anxiety & Stress Disorders

Screening for the symptom of worthlessness could save your adolescent patient’s life…

The experts weighed in on a wide variety of psychiatric issues for the October 2022 issue of Psychiatric Times.

"Among adults living in the United States, 38% to 40% use complementary and alternative medicine therapies, yet only 42% have told their primary physician that they do so."

At-home ketamine treatment initiated by an online provider presents many legal, clinical, and ethical challenges...

From historic USPSTF draft screening recommendations to the need for novel treatments for bipolar depression, here are highlights from the week in Psychiatric Times.

How can we increase assessment of anxiety without increasing other problems? Where is the balance?

For the first time, the USPSTF is recommending anxiety screening for adults under 65.

The first patient has been dosed in the phase 2b dose-optimization trial of a pharmaceutically optimized form of LSD for the treatment of generalized anxiety disorder.

With more immigrant students enrolling in US colleges, what can we do to help with their transition?

Treatments alter the neural processes underlying SAD symptoms.

The most common issues during the COVID-19 pandemic included stress, anxiety.

The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.

Here’s how to help patients—and ourselves—recognize cognitive distortions.

Treatment decisions lie on a continuum—befitting a dimensional approach to diagnosis.

Exploring cognitive biases toward the DSM and their avoidable effects on treatment decisions.

Research also shows increased prevalence of social risks and unmet social needs.

Individuals with ADHD are 4 times more likely to have generalized anxiety disorder at some point in their life.

Are your patients feeling stressed out? Here are 10 tips to share with them for a less stressful holiday season.

Why are psychotherapeutic interventions crucial in the treatment of GAD and anxiety disorders in general?

Loss and suffering can be hard for both patient and provider. Here’s what we know, what we need to learn, and how to protect yourself as a clinician.

PH94B for the treatment of social anxiety disorder further differentiates its mechanism of action from benzodiazepines in a new lab rat preclinical study.

A study compared matcha, a highly caffeinated green tea, to other sources of caffeine. Which had the greatest cognitive benefits?

What are some ways to overcome anxieties about returning to "normal"?

What can Olympians teach mental health professionals about caring for student athletes—and others too?

A patient presents with multiple substance use disorders super-imposed on mood and anxiety disorders. Where does a clinician even begin?